Aerovate Therapeutics
AVTE
#9342
Rank
NZ$0.11 B
Marketcap
$4.13
Share price
-0.84%
Change (1 day)
-86.47%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$0.94 Million

According to Aerovate Therapeutics's latest financial reports the company's total debt is NZ$0.94 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Aerovate Therapeutics - Total debt on balance sheet (from 2020 to 2024)

Total debt by year

Year Total debt Change
2022-12-31NZ$1.71 M104.29%
2021-12-31NZ$0.84 M
2020-12-31N/A-100%
2019-12-31NZ$3.71 M